NCT07473063Completed
Optimization of Heart Failure Treatment and Implementation of a Risk-based Patient Care Model.
Optimization of Treatment in Patients With a Diagnosis of Heart Failure and Realization of a Care Model Based on Risk Stratification
Source: ClinicalTrials.gov · Last updated 16 Mar 2026
Brief summary (registry, in English)
Collection of data from patients with heart failure, both in the acute phase (data collection during hospital admission) and in the chronic phase (data collection during outpatient follow-up), optimization of the treatment of patients with heart failure, and implementation of a care model based on risk stratification.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2428 (actual)
- First submitted
- 20 Feb 2026
- Start date
- Jan 2017
- Primary completion date
- Jun 2023
- Lead sponsor
- FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- Diseases
- Heart failure
- NCT number
- NCT07473063
What you commit to
- Study type: Observational
- Participants enrolled: 2428
- From Jan 2017 to the primary completion date, Jun 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Patients consecutively referred to the Cardiovascular Department with a diagnosis of acute heart failure between January 1, 2017 and May 31, 2020 and between June 1, 2020 and June 30, 2023.
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Asst Papa Giovanni Xxiii - Dip. Di Cardiologia Coordinator of this site? Confirm its status | Bergamo | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.